You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eribulin

Showing 26 - 50 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent, Neuropathy Trial in San Francisco (Eribulin, Cyclophosphamide)

Completed
Has Results
  • Malignant Solid Tumour
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2021

Breast Cancer Trial in London (Eribulin)

Terminated
Has Results
  • Breast Cancer
  • Eribulin
  • London, United Kingdom
    Charing Cross Hopsital
Jan 18, 2021

Triple Negative Breast Cancer Trial in Shanghai (Personalized treatment guided by mini-PDX and RNA sequencing, Nab paclitaxel,

Recruiting
  • Triple Negative Breast Cancer
  • Personalized treatment guided by mini-PDX and RNA sequencing
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)

Completed
Has Results
  • Metastatic Triple Negative Breast Cancer
  • pembrolizumab
  • +4 more
  • (no location specified)
Nov 9, 2021

Eribulin in the Treatment of Advanced Breast Cancer

Recruiting
  • Breast Cancer
  • Eribulin
  • +5 more
  • Guangzhou, Guangdong, China
    Sun Yat Sen Memorial Hospital，Sun Yat sen University
Dec 19, 2020

HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal

Active, not recruiting
  • HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer
  • +2 more
  • Ulm, Baden-Württemberg, Germany
    University Hospital Ulm -Department of Gynecology
Jul 27, 2022

Metastatic Breast Cancer Trial in Seoul (Paclitaxel, Eribulin, Gemcitabine)

Completed
  • Metastatic Breast Cancer
  • Seoul, Korea, Republic of
  • +1 more
Jul 12, 2020

Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)

Completed
Has Results
  • Metastatic Breast Cancer
  • San Francisco, California
  • +2 more
Jul 2, 2020

Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)

Recruiting
  • Triple Negative Breast Cancer
  • Amadora, Lisboa, Portugal
  • +16 more
Jun 10, 2022

Metastatic Breast Cancer Trial in France (Eribulin)

Withdrawn
  • Metastatic Breast Cancer
  • Eribulin
  • Angers, France
  • +6 more
May 5, 2020

Breast Cancer Trial in Guangzhou (Inetetamab, Pyrotinib, Capecitabine)

Recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun Yat Sen Memorial Hospital，Sun Yat sen University
Dec 18, 2020

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)

Unknown status
  • Metastatic Breast Cancer
  • Locally Recurrent Breast Cancer
  • Fresno, California
  • +87 more
Nov 26, 2020

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Metastatic Breast Cancer Trial in Spain, United Kingdom (PQR309, Eribulin)

Completed
  • Metastatic Breast Cancer
  • Barcelona, Catalan, Spain
  • +4 more
Mar 20, 2019

HER2-positive Locally Advanced or Metastatic Breast Cancer Trial in Chikusa-ku, Kumamoto City, Chuo-ku, Nihonbashi, Koami-cho

Unknown status
  • HER2-positive Locally Advanced or Metastatic Breast Cancer
  • Chikusa-ku, Aichi, Japan
  • +2 more
Jan 6, 2020

Advanced Breast Cancer Trial in Worldwide (Trastuzumab, Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Trastuzumab
  • +5 more
  • Graz, Austria
  • +107 more
Aug 8, 2022

Metastasis, Breast Cancer Trial in Worldwide (NKTR-102, Eribulin, Ixabepilone)

Completed
Has Results
  • Metastasis
  • Breast Cancer
  • Tucson, Arizona
  • +55 more
Aug 3, 2021

Breast Cancer Trial in United States (Eribulin)

Completed
Has Results
  • Breast Cancer
  • Eribulin
  • Bangor, Maine
  • +6 more
Jan 17, 2019

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pertuzumab, Trastuzumab, eribulin)

Terminated
Has Results
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
  • +1 more
Nov 9, 2018

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

HER-2 Positive Breast Cancer, Metastatic Tumor Trial in Worldwide (Margetuximab, Trastuzumab, Capecitabine)

Active, not recruiting
  • HER-2 Positive Breast Cancer
  • Metastatic Neoplasm
  • Margetuximab
  • +5 more
  • Chandler, Arizona
  • +166 more
Oct 18, 2021

NSCLC (NSCLC) Trial in Worldwide (Eribulin, TPC -Vinorelbine,Gemcitabine,Docetaxel, and Pemetrexed)

Completed
Has Results
  • Non-Small Cell Lung Cancer (NSCLC)
  • Eribulin
  • TPC -Vinorelbine,Gemcitabine,Docetaxel, and Pemetrexed
  • Los Angeles, California
  • +83 more
Jun 17, 2019

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022